✦ LIBER ✦

The Rationale for Using HMG-CoA Reductase Inhibitors (‘Statins’) in Peripheral Arterial Disease

✍ Scribed by G. Erez; E. Leitersdorf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rac1-Mediated Effects of HMG-CoA Reducta

✍ Adam, Oliver; Laufs, Ulrich 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 938 KB

The potential antigoitrogenic effect of

✍ Laszlo Hegedüs 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Monotherapy with hMG-CoA reductase inhib

✍ Charles E. Rackley 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 767 KB

Therapeutic Change of HMG-CoA Reductase

✍ Daniel E. Hilleman; Richard L. Wurdeman; Thomas L. Lenz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

The expanding role of HMG-CoA reductase

✍ Robert Chilton; Robert A. O'Rourke 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 906 KB

Relationships between HMG-CoA reductase

✍ Haerer, W.; Delbaere, K.; Bartlett, H.; Lord, S. R.; Rowland, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB